Business Daily from THE HINDU group of publications
Sunday, Sep 28, 2008
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Sunday, Sep 28, 2008 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Industry & Economy
-
Pharmaceuticals ‘Relax export norms to tap global clinical R&D market’
G. Naga Sridhar Hyderabad, Sept. 27 There is a need to relax the norms pertaining to export of body fluids and test samples to cash in on the huge opportunity in contract research and clinical trails, according to Mr Tapan Ray, Director-General, Organisation of Pharmaceutical Producers of India. “Pharma industry in India is over-regulated and there is a need for giving licences for export of body fluids and test samples. We have been requesting the Drug Controller General of India for this,” Mr Ray said on the sidelines of healthcare and pharma conclave at Indian School of Business here on Saturday. India potentialApart from tapping the potential in generics in view of many blockbuster drugs going off patent in the next few years, India could be a potential hub for contract research and development and outsourcing of clinical development, he said. The market for clinical studies outsourcing is estimated to be at $1 billion by 2010 and outsourcing of clinical development to India would help in cost-cutting for global majors. “According to an estimate prepared last year, the savings could be over $350 million for a single molecule,” he said. The time lags can also be brought down as clinical studies take 30-50 per cent of total R&D period for a new molecule. “This can be easier in India as we have a diversified patient profile and large number of specialty hospitals,” Mr Ray said. The key drivers for tapping the opportunity, however, would be R&D collaborations between companies and addressing the need for skilled human resources, he added. ‘We have a $20-m R&D budget for pure drug discovery’ Networking technologies — Driving pharma industry growth More Stories on : Pharmaceuticals | Exports & Imports
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
